58 related articles for article (PubMed ID: 33875571)
1. Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety.
Cornet A; Andersen J; Tani C; Mosca M
Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33875571
[TBL] [Abstract][Full Text] [Related]
2. Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.
Mercadé-Besora N; Guo Y; Du M; Li X; Ramírez-Anguita JM; Moreno A; Valente A; Villalobos F; Cheng IL; Carrasco-Ribelles LA; van Swieten MMH; Merkelbach M; Magoya M; Lasalvia P; Pericàs-Pulido P; Berg P; Bosco-Lévy P; Lillini R; Ribeiro R; Bagga TK; Ramella V; Khalid S; Mayer MA; Leis A; Jödicke AM; Burn E; Prieto-Alhambra D; Català M; Prats-Uribe A
Arthritis Care Res (Hoboken); 2024 Mar; ():. PubMed ID: 38523562
[TBL] [Abstract][Full Text] [Related]
3. Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate.
Pradelle A; Mainbourg S; Provencher S; Massy E; Grenet G; Lega JC
Biomed Pharmacother; 2024 Feb; 171():116055. PubMed ID: 38171239
[TBL] [Abstract][Full Text] [Related]
4. Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic.
Littlejohn E
Cleve Clin J Med; 2020 May; ():. PubMed ID: 32393597
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: A case report with detailed laboratory data.
Kondo M; Matsushima Y; Iida S; Umaoka A; Nakanishi T; Habe K; Yamanaka K
Clin Case Rep; 2021 Aug; 9(8):e04700. PubMed ID: 34466256
[TBL] [Abstract][Full Text] [Related]
6. Challenges in Chronic Genetic Disorders: Lessons From the COVID-19 Pandemic.
Pal S; Bhatia S; Bijarnia-Mahay S; Verma IC; Puri RD
Indian Pediatr; 2021 Apr; 58(4):391-392. PubMed ID: 33883315
[TBL] [Abstract][Full Text] [Related]
7. Patients with lupus are not protected from COVID-19.
Sawalha AH
Ann Rheum Dis; 2021 Feb; 80(2):e21. PubMed ID: 32332075
[No Abstract] [Full Text] [Related]
8. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
[TBL] [Abstract][Full Text] [Related]
9. Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.
Costagliola G; Spada E; Consolini R
Pediatr Rheumatol Online J; 2021 May; 19(1):68. PubMed ID: 33947420
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong.
Chua GT; Wong JSC; Lam I; Ho PPK; Chan WH; Yau FYS; Rosa Duque JS; Ho ACC; Siu KK; Cheung TWY; Lam DSY; Chan VCM; Lee KP; Tsui KW; Wong TW; Yau MM; Yau TY; Chan KCC; Yu MWL; Chow CK; Chiu WK; Chan KC; Wong WHS; Ho MHK; Tso WWY; Tung KTS; Wong CS; Kwok J; Leung WH; Yam JC; Wong ICK; Tam PKH; Chan GCF; Chow CB; To KKW; Lau YL; Yuen KY; Ip P; Kwan MYW
JAMA Netw Open; 2021 May; 4(5):e218824. PubMed ID: 33938934
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
[TBL] [Abstract][Full Text] [Related]
12. Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.
Muller R
Rheumatol Int; 2021 Jul; 41(7):1189-1202. PubMed ID: 33893862
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
Qiu R; Li J; Xiao Y; Gao Z; Weng Y; Zhang Q; Wang C; Gong H; Li W
Medicine (Baltimore); 2021 Apr; 100(16):e25532. PubMed ID: 33879694
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
Lekpa FK; Ngahane BHM; Njonnou SRS; Fouda H; Halle MP; Njankouo YM; Dzudie A; Choukem SP; Luma HN
Pan Afr Med J; 2021; 38():372. PubMed ID: 34367451
[TBL] [Abstract][Full Text] [Related]
15. Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial.
Randell RL; Singler L; Cunningham A; Schanberg LE; Cohen-Wolkowiez M; Hornik CP; Balevic SJ;
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33963084
[TBL] [Abstract][Full Text] [Related]
16. Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review.
Schlegel M; Bachmann S
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674242
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial impact of SARS- CoV-2 outbreak on patients with pediatric-onset systemic lupus erythematosus and their caregivers.
Sharma R; Chaudhary H; Patra P; Sudhakar M; Anjani G; Jindal A; Pandiarajan V; Gupta A; Suri D
J Family Med Prim Care; 2022 Dec; 11(12):7920-7925. PubMed ID: 36994004
[TBL] [Abstract][Full Text] [Related]
18. Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE - 18 months later.
Cornet A; Andersen J; Tani C; Mosca M;
Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36697031
[No Abstract] [Full Text] [Related]
19. Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later.
Gasnier M; Choucha W; Montani D; Noël N; Verstuyft C; Radiguer F; Monnet X; Becquemont L; Corruble E; Colle R;
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):762-767. PubMed ID: 36263650
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
Fu XL; Qian Y; Jin XH; Yu HR; Du L; Wu H; Chen HL; Shi YQ
Lupus; 2022 May; 31(6):684-696. PubMed ID: 35382637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
